<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-13-07754</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0071730</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Genetics</subject><subj-group><subject>Human genetics</subject><subj-group><subject>Genetic association studies</subject></subj-group></subj-group><subj-group><subject>Population genetics</subject><subj-group><subject>Genetic polymorphism</subject></subj-group></subj-group><subj-group><subject>Cancer genetics</subject></subj-group></subj-group><subj-group><subject>Population biology</subject><subj-group><subject>Population genetics</subject><subj-group><subject>Genetic polymorphism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Clinical research design</subject><subj-group><subject>Meta-analyses</subject></subj-group></subj-group><subj-group><subject>Epidemiology</subject><subj-group><subject>Genetic epidemiology</subject></subj-group></subj-group><subj-group><subject>Gastroenterology and hepatology</subject><subj-group><subject>Gastrointestinal cancers</subject></subj-group></subj-group><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Genitourinary tract tumors</subject><subj-group><subject>Prostate cancer</subject></subj-group></subj-group><subj-group><subject>Breast tumors</subject></subj-group></subj-group><subj-group><subject>Cancer risk factors</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Association between TCF7L2 Gene Polymorphism and Cancer Risk: A Meta-Analysis</article-title>
<alt-title alt-title-type="running-head">TCF7L2 Variant and Cancer Risk</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chen</surname><given-names>Jingxiang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yuan</surname><given-names>Tao</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>Menggang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chen</surname><given-names>Ping</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Department of Hepatobiliary Surgery, The Third Affiliated Hospital of the Third Military Medical University, Chongqing, China</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Department of Hepatobiliary Surgery, Jiangjin Central Hospital, Chongqing, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Deb</surname><given-names>Swati Palit</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Virginia Commonwealth University, United States of America</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">pingchen1956@163.com</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: PC. Performed the experiments: TY ML. Analyzed the data: JC PC. Contributed reagents/materials/analysis tools: TY ML. Wrote the paper: JC.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2013</year></pub-date>
<pub-date pub-type="epub"><day>9</day><month>8</month><year>2013</year></pub-date>
<volume>8</volume>
<issue>8</issue>
<elocation-id>e71730</elocation-id>
<history>
<date date-type="received"><day>21</day><month>2</month><year>2013</year></date>
<date date-type="accepted"><day>9</day><month>7</month><year>2013</year></date>
</history>
<permissions>
<copyright-year>2013</copyright-year>
<copyright-holder>Chen et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract><sec>
<title>Objective</title>
<p>The transcription factor 7-like 2 (<italic>TCF7L2</italic>) gene has been suggested to play an important role in the pathogenesis of cancer. However, the results have been inconsistent. In this study, we performed a meta-analysis to clarify the associations between <italic>TCF7L2</italic> polymorphism and cancer risk.</p>
</sec><sec>
<title>Methods</title>
<p>Published literature from PubMed and EMBASE were retrieved. Pooled odds ratios (ORs) with 95% confidence interval (CIs) were calculated using fixed- or random-effects model.</p>
</sec><sec>
<title>Results</title>
<p>A total of 19 studies (14,814 cases and 33,856 controls) were identified for the analysis of the association between <italic>TCF7L2</italic> polymorphism and cancer risk. The results showed that <italic>TCF7L2</italic> polymorphism was associated with breast cancer (Homogeneous model: OR = 1.17, 95%CI = 1.02–1.35, <italic>I</italic><sup>2</sup> = 21.8%, <italic>p</italic> for heterogeneity = 0.276; Heterogeneous model: OR = 1.11, 95%CI = 1.03–1.20, <italic>I</italic><sup>2</sup> = 0.0%, <italic>p</italic> for heterogeneity = 0.543), prostate cancer (Homogeneous model: OR = 0.89, 95%CI = 0.84–0.96, <italic>I</italic><sup>2</sup> = 0.0%, <italic>p</italic> for heterogeneity = 0.640; Heterogeneous model: OR = 0.89, 95%CI = 0.84–0.95, <italic>I</italic><sup>2</sup> = 0.0%, <italic>p</italic> for heterogeneity = 0.871), and colon cancer (Heterogeneous model: OR = 1.15, 95%CI = 1.01–1.31, <italic>I</italic><sup>2</sup> = 0.0%, <italic>p</italic> for heterogeneity = 0.658), but not with colorectal cancer, lung cancer, and ovarian cancer.</p>
</sec><sec>
<title>Conclusions</title>
<p>The present meta-analysis indicated that there were significantly associations between the <italic>TCF7L2</italic> rs7903146 polymorphism and risk of breast, prostate and colon cancers, rather than colorectal cancer, lung cancer, and ovarian cancer.</p>
</sec></abstract>
<funding-group><funding-statement>The authors have no support or funding to report.</funding-statement></funding-group><counts><page-count count="6"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>The transcription factor 7-like 2 (<italic>TCF7L2</italic>) gene, previously reported as <italic>TCF-4</italic>, has been found to be associated with type 2 diabetes. Rs7903146 variant of <italic>TCF7L2</italic> gene was firstly identified as one susceptibility marker of type 2 diabetes by genome-wide association study <xref ref-type="bibr" rid="pone.0071730-Salonen1">[1]</xref>. The following studies further confirmed the association between <italic>TCF7L2</italic> rs7903146 variant and type 2 diabetes <xref ref-type="bibr" rid="pone.0071730-Peng1">[2]</xref>. In addition, individuals carrying T alleles of <italic>TCF7L2</italic> rs7903146 variant demonstrated high risk of insulin resistance <xref ref-type="bibr" rid="pone.0071730-Lyssenko1">[3]</xref>. Alternatively, <italic>TCF7L2</italic> may affect cancer independently of diabetes, as the <italic>TCF7L2</italic> gene product is involved the Wnt/β-catenin signaling pathway. TCF7L2 forms an active nuclear complex with β-catenin that binds and induces the expression of target genes involved in cellular proliferation, evasion of apoptosis, and tissue invasion and metastasis.</p>
<p>To date, many studies have been published investigating the association between <italic>TCF7L2</italic> rs7903146 or rs12255372 (it is in high linkage disequilibrium with rs7903146) and several types of cancer, including breast cancer <xref ref-type="bibr" rid="pone.0071730-Burwinkel1">[4]</xref>–<xref ref-type="bibr" rid="pone.0071730-Connor1">[8]</xref>, prostate cancer <xref ref-type="bibr" rid="pone.0071730-Folsom1">[5]</xref>, <xref ref-type="bibr" rid="pone.0071730-Agalliu1">[9]</xref>–<xref ref-type="bibr" rid="pone.0071730-Machiela1">[12]</xref>, colorectal cancer <xref ref-type="bibr" rid="pone.0071730-Folsom1">[5]</xref>, <xref ref-type="bibr" rid="pone.0071730-Hazra1">[13]</xref>–<xref ref-type="bibr" rid="pone.0071730-Sainz1">[15]</xref>, colon cancer <xref ref-type="bibr" rid="pone.0071730-Folsom1">[5]</xref>, <xref ref-type="bibr" rid="pone.0071730-Slattery1">[16]</xref>, lung cancer <xref ref-type="bibr" rid="pone.0071730-Folsom1">[5]</xref> and ovarian cancer <xref ref-type="bibr" rid="pone.0071730-Goode1">[6]</xref>. However, the conclusions have been conflicting. Therefore, we performed a meta-analysis to clarify the association between <italic>TCF7L2</italic> rs7903146 variant and cancer risk.</p>
</sec><sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2a">
<title>Literature and Search Strategy</title>
<p>We searched the PubMed and EMBASE literature databases. The search strategy to identify all possible studies involved the use of the following key words: (<italic>TCF7L2</italic> or transcription factor 7-like 2 or <italic>TCF-4</italic>) and (variant or variation or polymorphism or genotype) and (cancer or carcinoma or tumor). All related studies published in English language were included. The reference lists of retrieved articles were hand-searched. If more than one article were published using the same case series, only the study with the latest data was included. The literature search was updated on February 18, 2013.</p>
</sec><sec id="s2b">
<title>Inclusion Criteria and Data Extraction</title>
<p>The studies included in the meta-analysis must meet all the following inclusion criteria: (1) evaluates the associations of <italic>TCF7L2</italic> polymorphism with cancer risk; (2) uses case–control or cohort design; and (3) provides sufficient data for calculation of odds ratio (OR) with 95% confidence interval (CI). The following information was extracted from each study: (1) name of the first author; (2) year of publication; (3) country of origin; (4) ethnicity; (5) cancer type; (6) sample size of cases and controls; (7) covariates’ adjusted OR with 95%CI under co-dominant model; (8) minor allele frequency in cases and controls; (9) <italic>p</italic> for Hardy Weinberg Equilibrium test in controls; and (10) studied polymorphism. The two authors independently assessed the articles for compliance with the inclusion/exclusion criteria, resolved disagreements and reached a consistent decision.</p>
</sec><sec id="s2c">
<title>Statistical Analysis</title>
<p>The association of <italic>TCF7L2</italic> polymorphism with cancer risk was estimated by calculating pooled ORs and 95%CIs under a co-dominant model. The significance of pooled OR was determined by Z test (P&lt;0.05 was considered statistically significant). Q test was performed to evaluate the between-study heterogeneity. A random- (DerSimonian-Laird method <xref ref-type="bibr" rid="pone.0071730-DerSimonian1">[17]</xref> or fixed- (Mantel–Haenszel method) <xref ref-type="bibr" rid="pone.0071730-Mantel1">[18]</xref> effects model was used to calculate pooled OR in the presence (<italic>P</italic>≤0.10) or absence (<italic>P</italic>&gt;0.10) of heterogeneity, respectively. Subgroup analysis by cancer type was performed to address the between-study heterogeneity. Publication bias was assessed by Begg’s test <xref ref-type="bibr" rid="pone.0071730-Begg1">[19]</xref> and Egger’s test <xref ref-type="bibr" rid="pone.0071730-Egger1">[20]</xref> (<italic>P</italic>&lt;0.05 was considered statistically significant). Data analysis was performed using STATA version 11 (StataCorp LP, College Station, TX, USA).</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Characteristics of the Studies</title>
<p>In this study, we followed the PRISMA Statement (<xref ref-type="supplementary-material" rid="pone.0071730.s001">Checklist S1</xref>). A flow chart describing the process of inclusion/exclusion of study is presented in <xref ref-type="fig" rid="pone-0071730-g001">Fig. 1</xref>. The literature search identified a total of 128 potentially relevant papers. Of them, 112 papers were excluded because of obvious irrelevance by reading the titles and abstracts. In addition, two papers were excluded because they were reviews. Then, 14 papers met the primary inclusion criteria. However, one paper was excluded because it did not provide sufficient data to calculate OR with 95%CI <xref ref-type="bibr" rid="pone.0071730-Domenyuk1">[21]</xref>. Since more than one study was included in two articles by Folsom et al <xref ref-type="bibr" rid="pone.0071730-Folsom1">[5]</xref> and Goode et al <xref ref-type="bibr" rid="pone.0071730-Goode1">[6]</xref>, they were considered as separate studies in the meta-analysis. In addition, since rs7903146 was in high LD with rs12255372, we combined all the included studies together. At last, 19 studies for the association between <italic>TCF7L2</italic> polymorphism and cancer risk were included in the final meta-analysis. Of them, five were on breast cancer, five were on prostate cancer, four were on colorectal cancer, two were on colon cancer, two were on lung cancer, and one was on ovarian cancer. The characteristics of the included studies are listed in <xref ref-type="table" rid="pone-0071730-t001">Table 1</xref>. It should be noted that because most studies provided covariates’ adjusted OR with 95%CI under a co-dominant model, we calculated the pooled estimate under this model only.</p>
<fig id="pone-0071730-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0071730.g001</object-id><label>Figure 1</label><caption>
<title>Flow chart of meta-analysis for exclusion/inclusion of individual articles (or studies).</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0071730.g001" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0071730-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0071730.t001</object-id><label>Table 1</label><caption>
<title>Characteristics of included studied of association between <italic>TCF7L2</italic> rs7903146 (or its proxy rs12255372) polymorphism and cancer risk.</title>
</caption><alternatives><graphic id="pone-0071730-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0071730.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Study</td>
<td align="left" rowspan="1" colspan="1">Country</td>
<td align="left" rowspan="1" colspan="1">Ethnicity</td>
<td align="left" rowspan="1" colspan="1">Cancer type</td>
<td colspan="2" align="left" rowspan="1">Sample size</td>
<td colspan="3" align="left" rowspan="1">Homogeneous co-dominant model</td>
<td colspan="3" align="left" rowspan="1">Heterogeneous co-dominant model</td>
<td colspan="2" align="left" rowspan="1">MAF</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic> for HWE</td>
<td align="left" rowspan="1" colspan="1">Studied SNP</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Cases</td>
<td align="left" rowspan="1" colspan="1">Controls</td>
<td align="left" rowspan="1" colspan="1">OR<xref ref-type="table-fn" rid="nt101">a</xref></td>
<td colspan="2" align="left" rowspan="1">95% CI</td>
<td align="left" rowspan="1" colspan="1">OR<xref ref-type="table-fn" rid="nt101">a</xref></td>
<td colspan="2" align="left" rowspan="1">95% CI</td>
<td align="left" rowspan="1" colspan="1">Cases</td>
<td align="left" rowspan="1" colspan="1">Controls</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Burwinkel,2006</td>
<td align="left" rowspan="1" colspan="1">Germany</td>
<td align="left" rowspan="1" colspan="1">European</td>
<td align="left" rowspan="1" colspan="1">Breast cancer</td>
<td align="left" rowspan="1" colspan="1">592</td>
<td align="left" rowspan="1" colspan="1">735</td>
<td align="left" rowspan="1" colspan="1">1.37</td>
<td align="left" rowspan="1" colspan="1">0.91</td>
<td align="left" rowspan="1" colspan="1">2.08</td>
<td align="left" rowspan="1" colspan="1">1.21</td>
<td align="left" rowspan="1" colspan="1">0.97</td>
<td align="left" rowspan="1" colspan="1">1.53</td>
<td align="left" rowspan="1" colspan="1">0.29</td>
<td align="left" rowspan="1" colspan="1">0.26</td>
<td align="left" rowspan="1" colspan="1">0.643</td>
<td align="left" rowspan="1" colspan="1">rs12255372</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Agalliu,2008</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">European</td>
<td align="left" rowspan="1" colspan="1">Prostate cancer</td>
<td align="left" rowspan="1" colspan="1">582</td>
<td align="left" rowspan="1" colspan="1">540</td>
<td align="left" rowspan="1" colspan="1">0.73</td>
<td align="left" rowspan="1" colspan="1">0.44</td>
<td align="left" rowspan="1" colspan="1">1.20</td>
<td align="left" rowspan="1" colspan="1">0.94</td>
<td align="left" rowspan="1" colspan="1">0.72</td>
<td align="left" rowspan="1" colspan="1">1.23</td>
<td align="left" rowspan="1" colspan="1">0.27</td>
<td align="left" rowspan="1" colspan="1">0.29</td>
<td align="left" rowspan="1" colspan="1">0.777</td>
<td align="left" rowspan="1" colspan="1">rs12255372</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Folsom,2008a</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Mixed</td>
<td align="left" rowspan="1" colspan="1">Colorectal cancer</td>
<td align="left" rowspan="1" colspan="1">180</td>
<td align="left" rowspan="1" colspan="1">11410</td>
<td align="left" rowspan="1" colspan="1">1.56</td>
<td align="left" rowspan="1" colspan="1">0.97</td>
<td align="left" rowspan="1" colspan="1">2.53</td>
<td align="left" rowspan="1" colspan="1">1.17</td>
<td align="left" rowspan="1" colspan="1">0.85</td>
<td align="left" rowspan="1" colspan="1">1.61</td>
<td align="left" rowspan="1" colspan="1">0.34</td>
<td align="left" rowspan="1" colspan="1">0.29</td>
<td align="left" rowspan="1" colspan="1">0.806</td>
<td align="left" rowspan="1" colspan="1">rs7903146</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Folsom,2008b</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Mixed</td>
<td align="left" rowspan="1" colspan="1">Colon cancer</td>
<td align="left" rowspan="1" colspan="1">128</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">2.15</td>
<td align="left" rowspan="1" colspan="1">1.27</td>
<td align="left" rowspan="1" colspan="1">3.64</td>
<td align="left" rowspan="1" colspan="1">1.25</td>
<td align="left" rowspan="1" colspan="1">0.85</td>
<td align="left" rowspan="1" colspan="1">1.83</td>
<td align="left" rowspan="1" colspan="1">0.36</td>
<td align="left" rowspan="1" colspan="1">0.29</td>
<td align="left" rowspan="1" colspan="1">0.806</td>
<td align="left" rowspan="1" colspan="1">rs7903146</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Folsom,2008c</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">European</td>
<td align="left" rowspan="1" colspan="1">Lung cancer</td>
<td align="left" rowspan="1" colspan="1">177</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">1.59</td>
<td align="left" rowspan="1" colspan="1">0.96</td>
<td align="left" rowspan="1" colspan="1">2.63</td>
<td align="left" rowspan="1" colspan="1">1.63</td>
<td align="left" rowspan="1" colspan="1">1.17</td>
<td align="left" rowspan="1" colspan="1">2.25</td>
<td align="left" rowspan="1" colspan="1">0.37</td>
<td align="left" rowspan="1" colspan="1">0.29</td>
<td align="left" rowspan="1" colspan="1">0.806</td>
<td align="left" rowspan="1" colspan="1">rs7903146</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Folsom,2008d</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Black</td>
<td align="left" rowspan="1" colspan="1">Lung cancer</td>
<td align="left" rowspan="1" colspan="1">62</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.62</td>
<td align="left" rowspan="1" colspan="1">0.22</td>
<td align="left" rowspan="1" colspan="1">1.76</td>
<td align="left" rowspan="1" colspan="1">0.75</td>
<td align="left" rowspan="1" colspan="1">0.44</td>
<td align="left" rowspan="1" colspan="1">1.3</td>
<td align="left" rowspan="1" colspan="1">0.26</td>
<td align="left" rowspan="1" colspan="1">0.29</td>
<td align="left" rowspan="1" colspan="1">0.806</td>
<td align="left" rowspan="1" colspan="1">rs7903146</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Folsom,2008e</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Mixed</td>
<td align="left" rowspan="1" colspan="1">Breast cancer</td>
<td align="left" rowspan="1" colspan="1">342</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.87</td>
<td align="left" rowspan="1" colspan="1">0.57</td>
<td align="left" rowspan="1" colspan="1">1.32</td>
<td align="left" rowspan="1" colspan="1">0.98</td>
<td align="left" rowspan="1" colspan="1">0.78</td>
<td align="left" rowspan="1" colspan="1">1.23</td>
<td align="left" rowspan="1" colspan="1">0.28</td>
<td align="left" rowspan="1" colspan="1">0.29</td>
<td align="left" rowspan="1" colspan="1">0.806</td>
<td align="left" rowspan="1" colspan="1">rs7903146</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Folsom,2008f</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Mixed</td>
<td align="left" rowspan="1" colspan="1">Prostate cancer</td>
<td align="left" rowspan="1" colspan="1">366</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">1.04</td>
<td align="left" rowspan="1" colspan="1">0.72</td>
<td align="left" rowspan="1" colspan="1">1.50</td>
<td align="left" rowspan="1" colspan="1">0.80</td>
<td align="left" rowspan="1" colspan="1">0.64</td>
<td align="left" rowspan="1" colspan="1">0.99</td>
<td align="left" rowspan="1" colspan="1">0.27</td>
<td align="left" rowspan="1" colspan="1">0.29</td>
<td align="left" rowspan="1" colspan="1">0.806</td>
<td align="left" rowspan="1" colspan="1">rs7903146</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hazra,2008</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">European</td>
<td align="left" rowspan="1" colspan="1">Colorectal cancer</td>
<td align="left" rowspan="1" colspan="1">357</td>
<td align="left" rowspan="1" colspan="1">814</td>
<td align="left" rowspan="1" colspan="1">0.63</td>
<td align="left" rowspan="1" colspan="1">0.37</td>
<td align="left" rowspan="1" colspan="1">1.08</td>
<td align="left" rowspan="1" colspan="1">0.90</td>
<td align="left" rowspan="1" colspan="1">0.68</td>
<td align="left" rowspan="1" colspan="1">1.18</td>
<td align="left" rowspan="1" colspan="1">0.25</td>
<td align="left" rowspan="1" colspan="1">0.29</td>
<td align="left" rowspan="1" colspan="1">0.497</td>
<td align="left" rowspan="1" colspan="1">rs12255372</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Slattery,2008</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Mixed</td>
<td align="left" rowspan="1" colspan="1">Colon cancer</td>
<td align="left" rowspan="1" colspan="1">1573</td>
<td align="left" rowspan="1" colspan="1">1962</td>
<td align="left" rowspan="1" colspan="1">1.03</td>
<td align="left" rowspan="1" colspan="1">0.80</td>
<td align="left" rowspan="1" colspan="1">1.33</td>
<td align="left" rowspan="1" colspan="1">1.14</td>
<td align="left" rowspan="1" colspan="1">0.99</td>
<td align="left" rowspan="1" colspan="1">1.31</td>
<td align="left" rowspan="1" colspan="1">0.29</td>
<td align="left" rowspan="1" colspan="1">0.28</td>
<td align="left" rowspan="1" colspan="1">0.878</td>
<td align="left" rowspan="1" colspan="1">rs7903146</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Goode,2009a</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">European</td>
<td align="left" rowspan="1" colspan="1">Breast cancer</td>
<td align="left" rowspan="1" colspan="1">779</td>
<td align="left" rowspan="1" colspan="1">830</td>
<td align="left" rowspan="1" colspan="1">0.92</td>
<td align="left" rowspan="1" colspan="1">0.62</td>
<td align="left" rowspan="1" colspan="1">1.36</td>
<td align="left" rowspan="1" colspan="1">1.16</td>
<td align="left" rowspan="1" colspan="1">0.93</td>
<td align="left" rowspan="1" colspan="1">1.43</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">0.28</td>
<td align="left" rowspan="1" colspan="1">0.23</td>
<td align="left" rowspan="1" colspan="1">rs12255372</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Goode,2009b</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">European</td>
<td align="left" rowspan="1" colspan="1">Ovarian cancer</td>
<td align="left" rowspan="1" colspan="1">391</td>
<td align="left" rowspan="1" colspan="1">458</td>
<td align="left" rowspan="1" colspan="1">0.97</td>
<td align="left" rowspan="1" colspan="1">0.56</td>
<td align="left" rowspan="1" colspan="1">1.68</td>
<td align="left" rowspan="1" colspan="1">0.95</td>
<td align="left" rowspan="1" colspan="1">0.71</td>
<td align="left" rowspan="1" colspan="1">1.26</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">0.26</td>
<td align="left" rowspan="1" colspan="1">0.96</td>
<td align="left" rowspan="1" colspan="1">rs12255372</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Tsilidis,2009</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Mixed</td>
<td align="left" rowspan="1" colspan="1">Colorectal cancer</td>
<td align="left" rowspan="1" colspan="1">202</td>
<td align="left" rowspan="1" colspan="1">354</td>
<td align="left" rowspan="1" colspan="1">1.44</td>
<td align="left" rowspan="1" colspan="1">0.81</td>
<td align="left" rowspan="1" colspan="1">2.57</td>
<td align="left" rowspan="1" colspan="1">1.13</td>
<td align="left" rowspan="1" colspan="1">0.78</td>
<td align="left" rowspan="1" colspan="1">1.66</td>
<td align="left" rowspan="1" colspan="1">0.32</td>
<td align="left" rowspan="1" colspan="1">0.28</td>
<td align="left" rowspan="1" colspan="1">0.196</td>
<td align="left" rowspan="1" colspan="1">rs7903146</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Wang,2009</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Mixed</td>
<td align="left" rowspan="1" colspan="1">Prostate cancer</td>
<td align="left" rowspan="1" colspan="1">249</td>
<td align="left" rowspan="1" colspan="1">249</td>
<td align="left" rowspan="1" colspan="1">0.62</td>
<td align="left" rowspan="1" colspan="1">0.32</td>
<td align="left" rowspan="1" colspan="1">1.20</td>
<td align="left" rowspan="1" colspan="1">0.94</td>
<td align="left" rowspan="1" colspan="1">0.62</td>
<td align="left" rowspan="1" colspan="1">1.42</td>
<td align="left" rowspan="1" colspan="1">0.27</td>
<td align="left" rowspan="1" colspan="1">0.30</td>
<td align="left" rowspan="1" colspan="1">0.151</td>
<td align="left" rowspan="1" colspan="1">rs7903146</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Meyer,2010</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Mixed</td>
<td align="left" rowspan="1" colspan="1">Prostate cancer</td>
<td align="left" rowspan="1" colspan="1">365</td>
<td align="left" rowspan="1" colspan="1">5757</td>
<td align="left" rowspan="1" colspan="1">0.88 <sup>b</sup></td>
<td align="left" rowspan="1" colspan="1">0.75</td>
<td align="left" rowspan="1" colspan="1">1.03</td>
<td align="left" rowspan="1" colspan="1">0.88 <sup>b</sup></td>
<td align="left" rowspan="1" colspan="1">0.75</td>
<td align="left" rowspan="1" colspan="1">1.03</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">0.30</td>
<td align="left" rowspan="1" colspan="1">&gt;0.05</td>
<td align="left" rowspan="1" colspan="1">rs7903146</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Machiela,2012</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">European</td>
<td align="left" rowspan="1" colspan="1">Prostate cancer</td>
<td align="left" rowspan="1" colspan="1">2782</td>
<td align="left" rowspan="1" colspan="1">4458</td>
<td align="left" rowspan="1" colspan="1">0.90 <sup>b</sup></td>
<td align="left" rowspan="1" colspan="1">0.83</td>
<td align="left" rowspan="1" colspan="1">0.97</td>
<td align="left" rowspan="1" colspan="1">0.90 <sup>b</sup></td>
<td align="left" rowspan="1" colspan="1">0.83</td>
<td align="left" rowspan="1" colspan="1">0.97</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">0.28</td>
<td align="left" rowspan="1" colspan="1">&gt;0.05</td>
<td align="left" rowspan="1" colspan="1">rs7903146</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Naidu,2012</td>
<td align="left" rowspan="1" colspan="1">Malaysia</td>
<td align="left" rowspan="1" colspan="1">Southeast Asian</td>
<td align="left" rowspan="1" colspan="1">Breast cancer</td>
<td align="left" rowspan="1" colspan="1">387</td>
<td align="left" rowspan="1" colspan="1">252</td>
<td align="left" rowspan="1" colspan="1">1.574</td>
<td align="left" rowspan="1" colspan="1">0.829</td>
<td align="left" rowspan="1" colspan="1">2.987</td>
<td align="left" rowspan="1" colspan="1">1.329</td>
<td align="left" rowspan="1" colspan="1">0.948</td>
<td align="left" rowspan="1" colspan="1">1.862</td>
<td align="left" rowspan="1" colspan="1">0.31</td>
<td align="left" rowspan="1" colspan="1">0.26</td>
<td align="left" rowspan="1" colspan="1">0.518</td>
<td align="left" rowspan="1" colspan="1">rs12255372</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sainz,2012</td>
<td align="left" rowspan="1" colspan="1">Germany</td>
<td align="left" rowspan="1" colspan="1">European</td>
<td align="left" rowspan="1" colspan="1">Colorectal cancer</td>
<td align="left" rowspan="1" colspan="1">1764</td>
<td align="left" rowspan="1" colspan="1">1749</td>
<td align="left" rowspan="1" colspan="1">1.28</td>
<td align="left" rowspan="1" colspan="1">1.01</td>
<td align="left" rowspan="1" colspan="1">1.63</td>
<td align="left" rowspan="1" colspan="1">1.13</td>
<td align="left" rowspan="1" colspan="1">0.98</td>
<td align="left" rowspan="1" colspan="1">1.30</td>
<td align="left" rowspan="1" colspan="1">0.31</td>
<td align="left" rowspan="1" colspan="1">0.28</td>
<td align="left" rowspan="1" colspan="1">0.435</td>
<td align="left" rowspan="1" colspan="1">rs7903146</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Connor,2012</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Mixed</td>
<td align="left" rowspan="1" colspan="1">Breast cancer</td>
<td align="left" rowspan="1" colspan="1">3523</td>
<td align="left" rowspan="1" colspan="1">4209</td>
<td align="left" rowspan="1" colspan="1">1.24</td>
<td align="left" rowspan="1" colspan="1">1.03</td>
<td align="left" rowspan="1" colspan="1">1.49</td>
<td align="left" rowspan="1" colspan="1">1.09</td>
<td align="left" rowspan="1" colspan="1">0.99</td>
<td align="left" rowspan="1" colspan="1">1.20</td>
<td align="left" rowspan="1" colspan="1">0.26</td>
<td align="left" rowspan="1" colspan="1">0.23</td>
<td align="left" rowspan="1" colspan="1">0.121</td>
<td align="left" rowspan="1" colspan="1">rs7903146</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label>a</label><p>Covariates’ adjusted estimate <sup>b</sup> Estimate under an additive model.</p></fn><fn id="nt102"><label/><p>MAF, minor allele frequency; NA, not available; HWE, Hardy Weinberg Equilibrium.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b">
<title>Meta-analysis Results</title>
<p>A total of 14814 cases and 33856 controls were identified for the analysis of the association between <italic>TCF7L2</italic> polymorphism with cancer risk. The results indicated that <italic>TCF7L2</italic> polymorphism might not be associated with cancer risk under co-dominant model (Homogeneous model: OR = 1.07, 95%CI = 0.95–1.21, <italic>I</italic><sup>2</sup> = 61.4%, <italic>p</italic> for heterogeneity&lt;0.001, <xref ref-type="fig" rid="pone-0071730-g002">Figure 2</xref>; Heterogeneous model: OR = 1.04, 95%CI = 0.97–1.12, <italic>I</italic><sup>2</sup> = 58.1%, <italic>p</italic> for heterogeneity = 0.001, <xref ref-type="fig" rid="pone-0071730-g003">Figure 3</xref>). However, further subgroup analysis by cancer type suggested that the effect size was significant for breast cancer (Homogeneous model: OR = 1.17, 95%CI = 1.02–1.35, <italic>I</italic><sup>2</sup> = 21.8%, <italic>p</italic> for heterogeneity = 0.276; Heterogeneous model: OR = 1.11, 95%CI = 1.03–1.20, <italic>I</italic><sup>2</sup> = 0.0%, <italic>p</italic> for heterogeneity = 0.543), prostate cancer (Homogeneous model: OR = 0.89, 95%CI = 0.84–0.96, <italic>I</italic><sup>2</sup> = 0.0%, <italic>p</italic> for heterogeneity = 0.640; Heterogeneous model: OR = 0.89, 95%CI = 0.84–0.95, <italic>I</italic><sup>2</sup> = 0.0%, <italic>p</italic> for heterogeneity = 0.871), and colon cancer (Heterogeneous model: OR = 1.15, 95%CI = 1.01–1.31, <italic>I</italic><sup>2</sup> = 0.0%, <italic>p</italic> for heterogeneity = 0.658), but not for colorectal cancer, lung cancer, and ovarian cancer (all <italic>p</italic>&gt;0.05, <xref ref-type="table" rid="pone-0071730-t002">Table 2</xref>).</p>
<fig id="pone-0071730-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0071730.g002</object-id><label>Figure 2</label><caption>
<title>Meta-analysis of association between <italic>TCF7L2</italic> rs7903146 polymorphism and cancer risk under homogeneous co-dominant model.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0071730.g002" position="float" xlink:type="simple"/></fig><fig id="pone-0071730-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0071730.g003</object-id><label>Figure 3</label><caption>
<title>Meta-analysis of association between <italic>TCF7L2</italic> rs7903146 polymorphism and cancer risk under heterogeneous co-dominant model.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0071730.g003" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0071730-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0071730.t002</object-id><label>Table 2</label><caption>
<title>Pooled ORs and 95%CIs of the association between <italic>TCF7L2</italic> rs7903146 (or its proxy rs12255372) polymorphism and cancer risk.</title>
</caption><alternatives><graphic id="pone-0071730-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0071730.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Contrasts</td>
<td align="left" rowspan="1" colspan="1">No. of studies (cases/controls)</td>
<td colspan="4" align="left" rowspan="1">Homogeneous co-dominant model</td>
<td colspan="4" align="left" rowspan="1">Heterogeneous co-dominant model</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">OR</td>
<td align="left" rowspan="1" colspan="1">95%CI</td>
<td align="left" rowspan="1" colspan="1"><italic>I</italic><sup>2</sup> (%)</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic> <sub>H</sub></td>
<td align="left" rowspan="1" colspan="1">OR</td>
<td align="left" rowspan="1" colspan="1">95%CI</td>
<td align="left" rowspan="1" colspan="1"><italic>I</italic><sup>2</sup> (%)</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic> <sub>H</sub></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">All</td>
<td align="left" rowspan="1" colspan="1">19 (14814/33856)</td>
<td align="left" rowspan="1" colspan="1">1.07</td>
<td align="left" rowspan="1" colspan="1">0.95–1.21</td>
<td align="left" rowspan="1" colspan="1">61.4</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.04</td>
<td align="left" rowspan="1" colspan="1">0.97–1.12</td>
<td align="left" rowspan="1" colspan="1">58.1</td>
<td align="left" rowspan="1" colspan="1">0.001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Cancer type</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Breast cancer</td>
<td align="left" rowspan="1" colspan="1">5 (5623/17436)<xref ref-type="table-fn" rid="nt103">a</xref></td>
<td align="left" rowspan="1" colspan="1">1.17</td>
<td align="left" rowspan="1" colspan="1">1.02–1.35</td>
<td align="left" rowspan="1" colspan="1">21.8</td>
<td align="left" rowspan="1" colspan="1">0.276</td>
<td align="left" rowspan="1" colspan="1">1.11</td>
<td align="left" rowspan="1" colspan="1">1.03–1.20</td>
<td align="left" rowspan="1" colspan="1">0.0</td>
<td align="left" rowspan="1" colspan="1">0.543</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Prostate cancer</td>
<td align="left" rowspan="1" colspan="1">5 (4358/22493)<xref ref-type="table-fn" rid="nt103">a</xref></td>
<td align="left" rowspan="1" colspan="1">0.89</td>
<td align="left" rowspan="1" colspan="1">0.84–0.96</td>
<td align="left" rowspan="1" colspan="1">0.0</td>
<td align="left" rowspan="1" colspan="1">0.640</td>
<td align="left" rowspan="1" colspan="1">0.89</td>
<td align="left" rowspan="1" colspan="1">0.84–0.95</td>
<td align="left" rowspan="1" colspan="1">0.0</td>
<td align="left" rowspan="1" colspan="1">0.871</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Colorectal cancer</td>
<td align="left" rowspan="1" colspan="1">4 (2502/14327)<xref ref-type="table-fn" rid="nt103">a</xref></td>
<td align="left" rowspan="1" colspan="1">1.18</td>
<td align="left" rowspan="1" colspan="1">0.84–1.66</td>
<td align="left" rowspan="1" colspan="1">59.1</td>
<td align="left" rowspan="1" colspan="1">0.062</td>
<td align="left" rowspan="1" colspan="1">1.09</td>
<td align="left" rowspan="1" colspan="1">0.98–1.22</td>
<td align="left" rowspan="1" colspan="1">0.0</td>
<td align="left" rowspan="1" colspan="1">0.507</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Colon cancer</td>
<td align="left" rowspan="1" colspan="1">2 (1710/13372)<xref ref-type="table-fn" rid="nt103">a</xref></td>
<td align="left" rowspan="1" colspan="1">1.43</td>
<td align="left" rowspan="1" colspan="1">0.70–2.94</td>
<td align="left" rowspan="1" colspan="1">83.6</td>
<td align="left" rowspan="1" colspan="1">0.014</td>
<td align="left" rowspan="1" colspan="1">1.15</td>
<td align="left" rowspan="1" colspan="1">1.01–1.31</td>
<td align="left" rowspan="1" colspan="1">0.0</td>
<td align="left" rowspan="1" colspan="1">0.658</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lung cancer</td>
<td align="left" rowspan="1" colspan="1">2 (239/11410)<xref ref-type="table-fn" rid="nt103">a</xref></td>
<td align="left" rowspan="1" colspan="1">1.11</td>
<td align="left" rowspan="1" colspan="1">0.45–2.73</td>
<td align="left" rowspan="1" colspan="1">60.8</td>
<td align="left" rowspan="1" colspan="1">0.110</td>
<td align="left" rowspan="1" colspan="1">1.14</td>
<td align="left" rowspan="1" colspan="1">0.53–2.44</td>
<td align="left" rowspan="1" colspan="1">82.7</td>
<td align="left" rowspan="1" colspan="1">0.016</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ovarian cancer</td>
<td align="left" rowspan="1" colspan="1">1 (391/458)</td>
<td align="left" rowspan="1" colspan="1">0.97</td>
<td align="left" rowspan="1" colspan="1">0.56–1.68</td>
<td align="left" rowspan="1" colspan="1">–</td>
<td align="left" rowspan="1" colspan="1">–</td>
<td align="left" rowspan="1" colspan="1">0.95</td>
<td align="left" rowspan="1" colspan="1">0.71–1.27</td>
<td align="left" rowspan="1" colspan="1">–</td>
<td align="left" rowspan="1" colspan="1">–</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt103"><label>a</label><p>Shared the same number of controls (<italic>n</italic> = 11410).</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3c">
<title>Potential Publication Bias</title>
<p>No publication bias could be detected under homogeneous co-dominant model (<italic>p</italic> = 0.780 for Begg’s test and <italic>p</italic> = 0.123 for Egger’s test) and heterogeneous co-dominant model (<italic>p</italic> = 0.889 for Begg’s test and <italic>p</italic> = 0.274 for Egger’s test).</p>
</sec></sec><sec id="s4">
<title>Discussion</title>
<p>To the best of our knowledge, our meta-analysis represents the first one investigating the association between <italic>TCF7L2</italic> rs7903146 polymorphism and cancer risk. The results suggested that <italic>TCF7L2</italic> rs7903146 polymorphism might not be associated with cancer risk. However, further stratified analysis demonstrated the significant association with breast cancer, prostate cancer and colon cancer, rather than colorectal cancer, lung cancer, and ovarian cancer.</p>
<p>Interestingly, the T allele of rs7903146 polymorphism, which has been associated with increased risk of type 2 diabetes, showed the inverse association with prostate cancer based on our meta-analysis. The finding was consistent with those from the individual studies by Folsom et al. <xref ref-type="bibr" rid="pone.0071730-Folsom1">[5]</xref> and Machiela et al <xref ref-type="bibr" rid="pone.0071730-Machiela1">[12]</xref>. However, the other three included studies did not suggest any association <xref ref-type="bibr" rid="pone.0071730-Agalliu1">[9]</xref>–<xref ref-type="bibr" rid="pone.0071730-Meyer1">[11]</xref>. In addition, we found positive association between rs7903146 polymorphism and breast cancer risk. Recently, Michailidou K et al. <xref ref-type="bibr" rid="pone.0071730-Michailidou1">[22]</xref> have found rs7904519 in intron 4 of <italic>TCF7L2</italic> (r<sup>2</sup> = 0.37 with rs7904519/rs12255372), to be associated with breast cancer. Further studies are necessary to examine the potential different mechanisms of <italic>TCF7L2</italic> polymorphism in various cancers.</p>
<p>Heterogeneity between studies is common in meta-analysis of genetic association studies. Although heterogeneity can be taken into account by performing a random-effects model, it would increase the odds of type I error <xref ref-type="bibr" rid="pone.0071730-Munaf1">[23]</xref>. We found significant between-study heterogeneity in the association of <italic>TCF7L2</italic> rs7903146 polymorphism with cancer risk. Therefore, subgroup analysis by cancer types was performed to explore the source of heterogeneity. The results showed that the between-study heterogeneity disappeared in several subgroups, but remained in other subgroups suggesting other covariates might confound the association.</p>
<p>The current meta-analysis has several strengths. First, OR (95% CI) after covariates adjustment from individual study was used to calculate the pooled the estimate, which increased the accuracy of effect estimate. Second, statistical power was greatly improved for the association study of <italic>TCF7L2</italic> rs7903146 polymorphism in the pooled analysis. However, several limitations should also be noted. First, the case – control study design does not allow for the inference of causality between the gene polymorphism and the outcome. Second, the effect of gene – gene/gene – environment interactions was not addressed in this meta-analysis. Third, although ethnicity plays an important role in the association of <italic>TCF7L2</italic> rs7903146 polymorphism with cancer risk, we did not perform the further subgroup analysis by ethnicity because of limited studies for each cancer type.</p>
<p>In conclusion, the results indicated that there was a significantly association between <italic>TCF7L2</italic> rs7903146 polymorphism and the risk of breast cancer, prostate cancer and colon cancer, rather than colorectal cancer, lung cancer, and ovarian cancer. Further well-designed large-scale studies with the consideration of gene–gene and gene–environment interactions should be conducted to investigate the association in future.</p>
</sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pone.0071730.s001" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0071730.s001" position="float" xlink:type="simple"><label>Checklist S1</label><caption>
<p><bold>PRISMA Checklist.</bold></p>
<p>(DOC)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pone.0071730-Salonen1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Salonen</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Uimari</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Aalto</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Pirskanen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kaikkonen</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Type 2 diabetes wholegenome association study in four populations: the DiaGen consortium</article-title>. <source>Am J Hum Genet</source> <volume>81</volume>: <fpage>338</fpage>–<lpage>345</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Peng1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peng</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Lü</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>TCF7L2 gene polymorphisms and type 2 diabetes risk: a comprehensive and updated meta-analysis involving 121,174 subjects</article-title>. <source>Mutagenesis</source> <volume>28</volume>: <fpage>25</fpage>–<lpage>37</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Lyssenko1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lyssenko</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Lupi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Marchetti</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Del Guerra</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Orho-Melander</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes</article-title>. <source>J Clin Invest</source> <volume>117</volume>: <fpage>2155</fpage>–<lpage>2163</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Burwinkel1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burwinkel</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Shanmugam</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Hemminki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Meindl</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Schmutzler</surname><given-names>RK</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study</article-title>. <source>BMC Cancer</source> <volume>6</volume>: <fpage>268</fpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Folsom1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Folsom</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Pankow</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Peacock</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Bielinski</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Heiss</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Variation in TCF7L2 and increased risk of colon cancer: the Atherosclerosis Risk in Communities (ARIC) Study</article-title>. <source>Diabetes Care</source> <volume>31</volume>: <fpage>905</fpage>–<lpage>909</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Goode1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goode</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Szabo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Prokunina-Olsson</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Vierkant</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Fredericksen</surname><given-names>ZS</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer</article-title>. <source>BMC Cancer</source> <volume>9</volume>: <fpage>312</fpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Naidu1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Naidu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Yip</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Taib</surname><given-names>NA</given-names></name> (<year>2012</year>) <article-title>Genetic variations in transcription factor 7-like 2 (TCF7L2) gene: association of TCF7L2 rs12255372(G/T) or rs7903146(C/T) with breast cancer risk and clinico-pathological parameters</article-title>. <source>Med Oncol</source> <volume>29(2)</volume>: <fpage>411</fpage>–<lpage>417</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Connor1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Connor</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Baumgartner</surname><given-names>RN</given-names></name>, <name name-style="western"><surname>Baumgartner</surname><given-names>KB</given-names></name>, <name name-style="western"><surname>Kerber</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Pinkston</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study</article-title>. <source>Breast Cancer Res Treat</source> <volume>136</volume>: <fpage>593</fpage>–<lpage>602</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Agalliu1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Agalliu</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Suuriniemi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Prokunina-Olsson</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Johanneson</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Collins</surname><given-names>FS</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study</article-title>. <source>Prostate</source> <volume>68</volume>: <fpage>740</fpage>–<lpage>747</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Wang1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Helzlsouer</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Hoffman-Bolton</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Clipp</surname><given-names>SL</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II</article-title>. <source>Prostate</source> <volume>69</volume>: <fpage>874</fpage>–<lpage>885</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Meyer1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meyer</surname><given-names>TE</given-names></name>, <name name-style="western"><surname>Boerwinkle</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Morrison</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Volcik</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Sanderson</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <volume>19</volume>: <fpage>558</fpage>–<lpage>565</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Machiela1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Machiela</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Lindström</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>NE</given-names></name>, <name name-style="western"><surname>Haiman</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Albanes</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium</article-title>. <source>Am J Epidemiol</source> <volume>176</volume>: <fpage>1121</fpage>–<lpage>1129</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Hazra1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hazra</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fuchs</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>AT</given-names></name>, <name name-style="western"><surname>Giovannucci</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Hunter</surname><given-names>DJ</given-names></name> (<year>2008</year>) <article-title>Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk</article-title>. <source>Cancer Causes Control</source> <volume>19</volume>: <fpage>975</fpage>–<lpage>980</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Tsilidis1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tsilidis</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Helzlsouer</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Grinberg</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Hoffman-Bolton</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer</article-title>. <source>Cancer Causes Control</source> <volume>20</volume>: <fpage>1739</fpage>–<lpage>1751</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Sainz1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sainz</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rudolph</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hoffmeister</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Frank</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Brenner</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Effect of type 2 diabetes predisposing genetic variants on colorectal cancer risk</article-title>. <source>J Clin Endocrinol Metab</source> <volume>97</volume>: <fpage>E845</fpage>–<lpage>8451</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Slattery1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Slattery</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Folsom</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Wolff</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Herrick</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Caan</surname><given-names>BJ</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Transcription factor 7-like 2 polymorphism and colon cancer</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <volume>17</volume>: <fpage>978</fpage>–<lpage>982</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-DerSimonian1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname><given-names>N</given-names></name> (<year>1986</year>) <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source> <volume>7</volume>: <fpage>177</fpage>–<lpage>188</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Mantel1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mantel</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Haenszel</surname><given-names>W</given-names></name> (<year>1959</year>) <article-title>Statistical aspects of the analysis of data from retrospective studies of disease</article-title>. <source>J Natl Cancer Inst</source> <volume>22</volume>: <fpage>719</fpage>–<lpage>748</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Begg1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname><given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Egger1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname><given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test. BMJ</article-title>. <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Domenyuk1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Domenyuk</surname><given-names>VP</given-names></name>, <name name-style="western"><surname>Litovkin</surname><given-names>KV</given-names></name>, <name name-style="western"><surname>Verbitskaya</surname><given-names>TG</given-names></name>, <name name-style="western"><surname>Dubinina</surname><given-names>VG</given-names></name>, <name name-style="western"><surname>Bubnov</surname><given-names>VV</given-names></name> (<year>2007</year>) <article-title>Identification of new DNA markers of endometrial cancer in patients from the Ukrainian population</article-title>. <source>Exp Oncol</source> <volume>29</volume>: <fpage>152</fpage>–<lpage>155</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071730-Michailidou1"><label>22</label>
<mixed-citation publication-type="other" xlink:type="simple">Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J,<etal>et al</etal>. (2013) Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 45: 353–61, 361e1–2.</mixed-citation>
</ref>
<ref id="pone.0071730-Munaf1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Munafò</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Flint</surname><given-names>J</given-names></name> (<year>2004</year>) <article-title>Meta-analysis of genetic association studies</article-title>. <source>Trends Genet</source> <volume>20</volume>: <fpage>439</fpage>–<lpage>444</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>